Skip to main content
. 2021 May 4;11:9512. doi: 10.1038/s41598-021-88970-6

Table 3.

Characteristics of patients with sepsis stratified according to the level of plasma HMGB1 from the validation cohort (n = 77).

Characteristics Overall Low HMGB1 (n = 56) High HMGB1 (n = 21) P value
Age, years 67 (59–75) 69 (55–76) 66 (63–71) 0.792
Gender, male 54 (70.1) 38 (67.9) 16 (76.2) 0.477
Co-morbidities
Cancer 43 (55.8) 29 (51.8) 14 (66.7) 0.242
Solid tumor 32 (41.6) 21 (37.5) 11 (52.4) 0.238
Hematologic malignancy 12 (15.6) 9 (16.1) 3 (14.3) 1.000
Diabetes 26 (33.8) 18 (32.1) 8 (38.1) 0.623
Chronic kidney disease 7 (9.1) 5 (8.9) 2 (9.5) 1.000
Myocardial infarction 4 (5.2) 2 (3.6) 2 (9.5) 0.298
Congestive heart failure 3 (3.9) 3 (5.4) 0 0.558
Cerebrovascular diseases 4 (5.2) 4 (7.1) 0 0.570
Charlson cormobidity index 2 (1–3) 2 (1–3) 2 (1–3) 0.751
Septic shock 53 (68.8) 37 (66.1) 16 (76.2) 0.393
Clinical status on ICU admission
Need for mechanical ventilation 34 (44.2) 24 (42.9) 10 (47.6) 0.708
Need for vasopressor support 62 (80.5) 46 (82.1) 16 (76.2) 0.537
Laboratory findings
PaO2/FiO2 ratio 233.8 (150.7–351.9) 222.7 (149.5–306.9) 302.5 (162.7–386.2) 0.153
CRP, mg/dL 13.1 (6.9–25.6) 12.2 (5.4–23.9) 15.4 (8.1–31.0) 0.088
Lactic acid, mg/dL 3.0 (1.9–4.6) 2.7 (1.7–4.2) 3.8 (2.2–4.9) 0.098
Severity of illness
SAPS 3 57 (48–65) 57 (47–63) 60 (54–66) 0.212
APACHE II score 25 (20–30) 25 (18–28) 29 (21–32) 0.084
Initial SOFA score 9 (7–11) 9 (7–11) 10 (8–12) 0.052
7-day mortality 1 (1.3) 0 1 (4.8) 0.273
28-day mortality 9 (11.7) 2 (3.6) 7 (33.3) 0.001
90-day mortality 21 (27.3) 10 (17.9) 11 (52.4) 0.002
In-hospital mortality 17 (22.1) 7 (12.5) 10 (47.6) 0.002

APACHE II, acute physiology and chronic health evaluation II; CRP, C-reactive protein; ICU, intensive care unit; PaO2/FiO2, arterial partial pressure of oxygen/fraction of inspired oxygen; SAPS 3, simplified acute physiology score 3; SOFA, sequential organ failure assessment.